Prognostic Value of Admission Mean Corpuscular Volume for Major Adverse Cardiovascular Events following Stent Implantation in Nondiabetic and Diabetic Patients with Acute Coronary Syndrome

Table 4

Landmark analysis of MACEs in whole and nondiabetic patients.

Variable	Hazard ratio (95% CI)	SEM	value
Whole (≤32 months)
MCV-L	Reference
MCV-M^b	1.359 (0.536-3.447)	0.478	0.518
MCV-H^b	2.979 (1.331-6.671)	0.411	0.020
Whole (>32 months to maximum follow-up)
MCV-L	Reference
MCV-M^b	0.933 (0.447-1.945)	0.375	0.852
MCV-H^b	1.410 (0.675-2.948)	0.376	0.361
Non-DM (≤32 months)
MCV-L	Reference
MCV-M^b	1.400 (0.334-5.864)	0.731	0.645
MCV-H^b	4.054 (1.192-13.789)	0.625	0.025
Non-DM (>32 months to maximum follow-up)
MCV-L	Reference
MCV-M^b	1.119 (0.420-2.985)	0.501	0.822
MCV-H^b	1.596 (0.647-3.936)	0.461	0.310

ACS: acute coronary syndrome; MACEs: major adverse cardiovascular events; MCV: mean corpuscular volume; CI: confidence interval; SEM: standard error of measurement. ^bCompared with MCV-L group.